New Haven Pharmaceuticals, Inc.

New Haven Pharmaceuticals, Inc.
Espero Pharmaceuticals Inc. has acquired worldwide rights to New Haven Pharmaceuticals Inc.’s FDA-approved Durlaza (aspirin) extended-release capsules. February 2017.
http://www.sci.bio/job-search/

Send Message to listing owner

New Haven Pharmaceuticals, Inc.